BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9858879)

  • 1. Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression.
    Crowe DL; Boardman ML; Fong KS
    Anticancer Res; 1998; 18(5A):3163-70. PubMed ID: 9858879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common pathway for chemotherapy-induced apoptosis in human squamous cell carcinoma lines distinct from that of receptor-mediated cell death.
    Crowe DL; Yoon E
    Anticancer Res; 2003; 23(3B):2321-8. PubMed ID: 12894510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
    Brás A; Albar JP; Leonardo E; de Buitrago GG; Martínez-A C
    Cell Death Differ; 2000 Mar; 7(3):262-71. PubMed ID: 10745271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.
    Ochs K; Kaina B
    Cancer Res; 2000 Oct; 60(20):5815-24. PubMed ID: 11059778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation.
    Lamboley C; Bringuier AF; Feldmann G
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):13-28. PubMed ID: 10726968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
    Gil J; Esteban M
    Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
    Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
    Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
    Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas.
    Legembre P; Moreau P; Daburon S; Moreau JF; Taupin JL
    Cell Death Differ; 2002 Mar; 9(3):329-39. PubMed ID: 11859415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
    Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
    Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independent.
    Metkar SS; Anand M; Manna PP; Naresh KN; Nadkarni JJ
    Exp Cell Res; 2000 Feb; 255(1):18-29. PubMed ID: 10666330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines.
    Gewies A; Rokhlin OW; Cohen MB
    Cancer Res; 2000 Apr; 60(8):2163-8. PubMed ID: 10786680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
    Kataoka T; Ito M; Budd RC; Tschopp J; Nagai K
    Exp Cell Res; 2002 Feb; 273(2):256-64. PubMed ID: 11822881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.